- Filed
- Sep 29, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 5, 2025 | 81.25M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 78.35M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 69.72M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 60.99M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 60.13M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $27K |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $12.61M |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $9K |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $207K |
| Capex | Q3 2025 · Mar 31, 2025 | $2.82M |
| Capex | Q3 2025 · Mar 31, 2025 | $13.1M |
| Capex | Q3 2025 · Mar 31, 2024 | $2.94M |
| Capex | Q3 2025 · Mar 31, 2024 | $7.95M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | $10.66M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$2.64M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $19.18M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $23.14M |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $166.61M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $127.47M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $71.01M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $59.07M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $55.22M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $185.23M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $175.86M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $155.02M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $129.89M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $368.22M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $303.16M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $212.44M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $187.7M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $649.2M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $558.45M |
| Eps Diluted restated | Q3 2025 · Mar 31, 2025 | −$0.27 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2025 | −$0.81 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.06 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.20 |
| Eps Basic restated | Q3 2025 · Mar 31, 2025 | −$0.27 |
| Eps Basic restated | Q3 2025 · Mar 31, 2025 | −$0.81 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.20 |
| Sga Expense restated | Q3 2025 · Mar 31, 2025 | $34.22M |
| Sga Expense restated | Q3 2025 · Mar 31, 2025 | $97.21M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $23.12M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $67.15M |
| Net Income restated | Q3 2025 · Mar 31, 2025 | −$22.06M |
| Net Income restated | Q3 2025 · Mar 31, 2025 | −$58.73M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$4.05M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$12.41M |
| Operating Income restated | Q3 2025 · Mar 31, 2025 | $569K |
| Operating Income restated | Q3 2025 · Mar 31, 2025 | $1.3M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $794K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $3.3M |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2025 | $117.01M |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2025 | $366.62M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $107.85M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $329.61M |
| Revenue restated | Q3 2025 · Mar 31, 2025 | $161.45M |
| Revenue restated | Q3 2025 · Mar 31, 2025 | $491.23M |
| Revenue | Q3 2025 · Mar 31, 2024 | $138.19M |
| Revenue | Q3 2025 · Mar 31, 2024 | $418.18M |